Quiero saber acerca de...

316

Federal Register / Vol. 86, No. 2 / Tuesday, January 5, 2021 / Notices
Notice of these meetings is given under the Federal Advisory Committee Act 5
U.S.C. App. 2, section 10a1 and a2. Topics of the Meeting: Impact of COVID19 on people with dementia, health disparities in dementia research, and the implications of new technologies to identify Alzheimers disease through a blood tests.
Procedure and Agenda: The meeting will be webcast at www.hhs.gov/live and video recordings will be added to the National Alzheimers Project Act website when available, after the meeting.

SUPPLEMENTARY INFORMATION:

Authority: 42 U.S.C. 11225; Section 2e3
of the National Alzheimers Project Act. The panel is governed by provisions of Public Law 92463, as amended 5 U.S.C. Appendix 2, which sets forth standards for the formation and use of advisory committees.
Dated: December 21, 2020.
Brenda Destro, Deputy Assistant Secretary for Planning and Evaluation, Office of Human Services Policy.
FR Doc. 202029141 Filed 1421; 8:45 am BILLING CODE 415005P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jbell on DSKJLSW7X2PROD with NOTICES

Name of Committee: Board of Scientific Counselors, NHLBI.
Date: February 1, 2021.
Time: 8:45 a.m. to 6:00 p.m.
Agenda: To review and evaluate personnel qualifications and performance, and competence of individual investigators.
Place: National Institutes of Health, Building 10, 10 Center Drive, Bethesda, MD
20892 Virtual Meeting.
Contact Person: Robert S. Balaban, Ph.D., Scientific Director, Division of Intramural Research, National Institutes of Health,
Jkt 253001

Dated: December 29, 2020.
David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy.

National Institutes of Health
BILLING CODE 414001P

Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552bc6, Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Heart, Lung, and Blood Institute, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

17:09 Jan 04, 2021

Date: March 1012, 2021.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 Video Meeting.
Contact Person: Charlene J. Repique, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7347, 6707 Democracy Boulevard, Bethesda, MD 208925452, 301 5947791, charlene.repique@nih.gov.
Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS
Dated: December 29, 2020.
Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202029148 Filed 1421; 8:45 am BILLING CODE 414001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

National Institute on Aging; Notice of Closed Meeting
FR Doc. 202029124 Filed 1421; 8:45 am
National Heart, Lung, and Blood Institute; Notice of Closed Meeting
VerDate Sep<11>2014

NHLBI Building 10, CRC, 4th Floor, Room 1581, 10 Center Drive, Bethesda, MD 20892, 301 4962116, balabanr@nhlbi.nih.gov.
Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.
In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification for example, a government-issued photo ID, drivers license, or passport and to state the purpose of their visit.
Information is also available on the Institutes/Centers home page:
www.nhlbi.nih.gov/meetings/index.htm, where an agenda and any additional information for the meeting will be posted when available.
Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Initial Review Group; Diabetes, Endocrinology and Metabolic Diseases DDK
B Subcommittee.

PO 00000

Frm 00032

Fmt 4703

Sfmt 4703

Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Aging Special Emphasis Panel; Preclinical Development of Aging Therapeutics.
Date: February 18, 2021.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 Video Meeting.
Contact Person: Birgit Neuhuber, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute on Aging, National Institutes of Health, 7201 Wisconsin Avenue, Gateway Building, Suite 2W200, Bethesda, MD 20892, 301 4801266, neuhuber@
ninds.nih.gov.

E:FRFM05JAN1.SGM

05JAN1